Does TUCIDINOSTAT Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with TUCIDINOSTAT. This represents 2.0% of all adverse event reports for TUCIDINOSTAT.
5
Reports of Malignant neoplasm progression with TUCIDINOSTAT
2.0%
of all TUCIDINOSTAT reports
3
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TUCIDINOSTAT?
Of the 5 reports, 3 (60.0%) resulted in death, and 1 (20.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TUCIDINOSTAT. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TUCIDINOSTAT Cause?
Myelosuppression (85)
Disease progression (37)
Anaemia (33)
Pneumonia (30)
Off label use (28)
Platelet count decreased (24)
Nausea (22)
White blood cell count decreased (21)
Drug ineffective (19)
Treatment failure (16)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TUCIDINOSTAT Alternatives Have Lower Malignant neoplasm progression Risk?
TUCIDINOSTAT vs TYKERB
TUCIDINOSTAT vs TYLENOL
TUCIDINOSTAT vs TYROTHRICIN
TUCIDINOSTAT vs TYSABRI
TUCIDINOSTAT vs TYVASO